Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zymeworks Inc. - Common Stock (NY:ZYME)

N/A UNCHANGED
Last Price Updated: 7:00 PM EST, Dec 15, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zymeworks Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
$10K to $100K: Small-Cap Marvels With Massive Upside
Transform $10K to $100K with top small-cap stocks. Discover market marvels with massive upside for savvy investors. 
Via InvestorPlace
Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks Announces Additional Leadership Appointments
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks Announces $50 Million Private Placement to EcoR1 Capital
Proceeds expected to extend cash runway into H2 2027 
From Zymeworks Inc.
Via GlobeNewswire
Recap: Zymeworks Q3 Earnings
Via Benzinga
Small-Cap Sensations: 3 Stocks Predicted for Massive Growth in 2024
These three small-cap stocks have massive return potential in 2024 and beyond, according to analyst forecasts and broader industry trends. 
Via InvestorPlace
From $10k to $100k in 5 years: 3 Small-Cap Stocks to Make a Fortune
Are you looking for small-cap stocks to get rich? Turn $10k to $100k in 5 years in the stock market with these stocks. 
Via InvestorPlace
Want to Turn Spare Change Into $1,000? Buy These 3 Stocks Now
Three high conviction stocks seem perfect for opportunistic investors and could quickly transform spare change into four-figure returns. 
Via InvestorPlace
Zymeworks Added to Nasdaq Biotechnology Index
From Zymeworks Inc.
Via GlobeNewswire
Next Wave Biotech: 3 Stocks Poised for Breakthrough Success
The overall sector may be struggling after COVID, but there's still great potential in these three biotech stocks. 
Via InvestorPlace
Exposures COVID-19
The 7 Best Bargain Growth Stocks to Buy Before 2024
These bargain growth stocks offer significant upside potential alongside decent margins of safety, for those seeking impressive value. 
Via InvestorPlace
5 Value Stocks In The Healthcare Sector
Via Benzinga
Zymeworks Announces Participation in Upcoming Investor Conference
From Zymeworks Inc.
Via GlobeNewswire
3 Beaten-Down Stocks to Buy for 1,000% Upside in Five Years
Many stocks now trade at tempting valuations, and these three beaten-down stocks could soar 1,000% within five years. 
Via InvestorPlace
7 Healthcare Stocks That Are Poised to Become the Next Unicorns
Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments. 
Via InvestorPlace
Zymeworks Provides Corporate Update and Reports Third Quarter 2023 Financial Results
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks To Host Third Quarter 2023 Results Conference Call
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks Announces New Director Nominee
From Zymeworks Inc.
Via GlobeNewswire
Earnings Scheduled For November 7, 2023
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. 
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
Revolutionary Cancer Treatment Advances Promise Brighter Future Amid Federal Funding Uncertainty
FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 22, 2023 – USA News Group – Despite the potential federal funding challenges due to the recent debt ceiling deal,... 
Via FinancialNewsMedia
The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023
All of these healthcare stocks to buy are underpriced and relatively stable investments over the mid-to-long term. 
Via InvestorPlace
Zymeworks Provides Corporate Update and Reports Second Quarter 2023 Financial Results
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
From Zymeworks Inc.
Via GlobeNewswire
7 Small-Cap Stocks to Buy Before the Breakout
If you don’t mind the extreme risks involved, growth investors should target these ideas for best small cap stocks to buy. 
Via InvestorPlace
5 Value Stocks In The Healthcare Sector
Via Benzinga
Earnings Scheduled For August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
Via Benzinga
Zymeworks To Host Second Quarter 2023 Results Conference Call
From Zymeworks Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.